Welcome

Join This Group

I hope this will be a place that people can come together and support one another when dealing with pain or health challenges with a focus on HOW to be your own best advocate when it comes to your healthcare needs and how to get the respect of the medical community that you DESERVE. Would be great to have a mix of people that have learned what their "rights" are(I know this is up for debate)and have found ways to achieve what is in THEIR best interest for their health care and share wi

  • Talking to your Dr. about Pain

    Posted by lladyfairhair - 12/05/08, 09:50 pm

    Health tips: advice for talking to your doctor about painGet the most out of your doctor's visit by using these helpful suggestions on how to talk...

  • Nothing to Fear but Pain Itself

    Posted by lladyfairhair - 12/03/08, 06:19 pm

    Nothing to Fear but Pain ItselfAre You Opio-Phobic? By Peggy Peck WebMD Feature Aug. 13, 2001 -- Oncology nurse specialist Carol Blecher, RN, MS, AOCN...

  • White and gray matter abnormalities in the brain

    Posted by lladyfairhair - 12/02/08, 01:37 am

       White and gray matter abnormalities in the brain of patients with fibromyalgia: A diffusion-tensor and volumetric imaging study - So...

Group News

National Pain Care Policy Act

Posted by lladyfairhair - 02/13/09, 05:50 pm
Decade of Pain Control and Research

In late 2000, Congress passed into law a provision, which the President signed, that declared the ten-year period that began January 1, 2001, as the Decade of Pain Control and Research. The American Pain Society has actively supported the Decade of Pain Control and Research, and it has been a focal point for the development of numerous programs to advance awareness and treatment of pain and funding for research.

APS Decade of Pain Initiatives National Pain Care Policy Act

Working in collaboration with its partners in the Pain Care Coalition (American Academy of Pain Medicine, American Headache Society, and American Society of Anesthesiology) APS has been active in advocating for the passage of the National Pain Care Policy Act, currently HR 1020. First introduced in 2003 as HR 1863 by Representative Mike Rogers (R- MI), the act calls for the establishment of six regional pain centers. Other provisions would

establish a White House Conference on Pain to raise awareness of pain as a significant national health problem and identify barriers to appropriate pain care.create a pain and palliative care research and quality program within the Agency for Health Care Quality and Research.ensure that American military personnel and veterans receive appropriate pain care services at VA healthcare facilities.ensure that patients enrolled in Medicare managed care plans receive appropriate pain care.authorize a public awareness campaign by HHS to educate patients, families, and other caregivers on pain care.

Representatives of APS have testified in Congressional hearings and called on Congressional representatives to inform them of the need for increased public resources to improve the plight of millions living with severe or chronic pain. (See related content and current status of the bill)

Annual Lectureship

APS has established an annual Decade of Pain Control and Research Lecture at its annual scientific meeting. Lecturers have included:

John Loeser, MD, The Decade of Pain Control and Research, March 20, 2003, 22nd Annual Scientific Meeting, Chicago

Michael Ashburn, MD and Mary Ellen Jeans, PhD, Influencing the Policy Agenda to Support Improved Pain Management, May 6, 2004, Joint APS and Canadian Pain Society Annual Scientific Meeting, Vancouver

David Joranson, MSSW, March 31, 2005, 24th Annual Scientific Meeting, Boston

Ronald Dubner, DDS, Pain Research: A Model for Translational Research in the 21st Century, May 5, 2006, 25th Annual Scientific Meeting, San Antonio

Journalism Award

In an effort to recognize and promote better reporting on pain issues, APS established the Kathleen Foley Journalist Award for Excellence in Pain Reporting. This award is presented annually at the APS annual meeting. Recipients of the award include:

2003: Modern Maturity, William Heavey2004: Canadian Broadcasting Corporation, Philip Coulter2004: Newsweek, Claudia Kalb, Anne Underwood, Karen Springen2005: Arthritis Today, Jean Doran and Donna Rea Siegfried2006: New York Times, Jane Brody2007: Charleston Gazette, Scott Finn and Tara Tuckwiller Small Grants Program

As part of its mission to provide resources for members interested in contributing to the evidence base for pain, APS has developed its Future Leaders in Pain Research Small Grants Program. This grant program was established to fund research projects of doctorally-prepared investigators who have not yet attained NIH RO1 level funding, with the purpose of adding to the body of knowledge on pain. The grants program was made possible by unrestricted grants from Endo Pharmaceuticals and Cephalon.

This grants program was launched in 2005, with three grants of $16,000. In its second year, funding was increased and five grants of $20,000 each were awarded. A committee of NIH-funded APS investigators served as a committee of reviewers for the grant applications. Grant recipients and projects APS has funded to date include:

2005 Grant Recipients

Barbara A. Hastie, PhD MA, University of Florida College of Dentistry: Ethnic Differences in Acute Pain and Analgesic Side Effects

Robert R. Edwards, PhD MSPG, Johns Hopkins University School of Medicine: Individual Differences in Pain Modulation as a Predictor of Long-Term Pain and Analgesic Use in Women Following Surgical Management of Breast Cancer

Susan G. Dorsey, PhD MS, University of Maryland, Baltimore, School of Nursing: Development of a Mouse Model of HIV Therapy-Induced painful Peripheral Neuropathy

2006 Grant Recipients

Marie Hoeger Bement, PT PhD, Marquette University: Acute Hormonal Fluctuations as a Mechanism for Exercise-Induced Hypoalgesia in Women

Beth D. Darnall, PhD, Oregon Health & Science University: A Prospective Investigation of Immunologic Response to Negative Cognition in Persons with Chronic Pain

Jill C. Fehrenbacher, PhD, University of Texas Health Science Center - San Antonio: Sex-dependent modulation of clinical outcomes following laparoscopic cholecystectomy

Bryan C. Hains, PhD, Yale University: Supraspinal modulation of pain after SCI by microglia

Theodore J. Price, PhD, McGill University: Role of RNA transport and local translation in nociceptive processing

Professional Awareness and Education about Pain

Strategies to enhance provider awareness and competency in assessing and treating pain are an important part of the overall strategy for the Decade of Pain Control and Research. Two projects have been launched to bring tools to clinicians in primary care and specialty care settings. The first is Pain Control in the Primary Care Setting (link to Online store page), (?2006) a monograph delineating basic principles of pain assessment, diagnosis and treatment that includes a series of case studies and references to other resources.

A second initiative in progress is to convert Principles of Analgesic Use in the Treatment of Acute Pain and Cancer Pain to a PDA format to widen its audience and enhance its usability. The guide is a popular handbook covering indications and uses of both opioid and nonopioid analgesics, including dosages and side effects management. The PDA launch is anticipated to occur concurrent with the publication of the 6th edition of the guide, in 2007.

Good article re: pain medications

Posted by lladyfairhair - 12/23/08, 10:21 pm
Medications

Numerous medications are available for the treatment of back and neck pain with or without pain in the legs and arms. The choice of medication depends on whether your pain is muscle and bone pain (nociceptive), nerve pain (neuropathic), or a mixture of both.

1. Muscle and Bone (Nociceptive) Pain: In general, the categories of medications used to treat nociceptive back and neck pain include:

Non-steroidal anti-inflammatory drugs (NSAIDs) Narcotic medications or opioids Tranquilizing medications Anticonvulsant medication or antiepileptic medication Steroidal anti-inflammatory medication

a. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)

Traditionally, NSAIDs are used to treat muscle and bone pain. Many of these drugs are household terms, such as ibuprofen (Advil) and naproxen (Aleve). Others are newer and more expensive, such as COX-2 inhibitors: celecoxib (Celebrex). As a group, these agents are widely prescribed.

While NSAIDs are widely prescribed and effective in reducing acute pain and inflammation, they have significant side effects, especially taken for long periods of time. The most common side effects of NSAIDs are gastrointestinal bleeding, bleeding disorder (but not related to taking COX-2 inhibitors), hypertension and fluid retention. Although all of the NSAIDs can cause stroke or heart attack, they rarely do so. Used long-term or with other medications, some NSAIDs also have been associated with liver problems.

b. Narcotic or Opioid Medications

The most widely used prescription pain drugs are commonly known as "narcotics." The term narcotic is an old Greek word meaning "sleep." The preferred modern term for these medications is "opioids." Opioids act on the brain relay systems for the normal processing of pain. Commonly prescribed opioid pain medications include:

codeine (Tylenol #3) hydrocodone (Vicodin, Lorcet, Zydone, Norco) oxycodone (Percocet, Oxy IR, Roxicodone, or Oxycontin) morphine ( Avinza, MS Contin, Oramorph or Kadian) fentanyl (Duragesic or Actique) methadone (methadone or methadose)

c. Muscle Relaxants

Some pain medications act more by relaxing muscles than as direct central nervous system pain relievers. Commonly prescribed muscle relaxants include:

carisoprodol (Soma) diazepam (Valium) methocarbamol (Robaxin) tizanidine (Zanaflex) cyclobenzaprine (Flexeril) The US Food and Drug Administration (FDA) does not recommend the long-term use of muscle relaxants because they no longer are effective in actual muscle relaxation after two weeks of use. Soma or carisoprodol is metabolized to the sedative meprobamate in the body and can be habit forming.

Some drugs such as acetaminophen (Tylenol) and paracetamol (a popular European acetaminophen-like medication) are thought to provide pain relief via central brain mechanisms.

2. Nerve Pain (Neuropathic)

The treatment for nerve pain focuses on the use of medications that are not normally labeled as pain relievers, but because of their properties they may help the body fight the pain. These medications are called "adjuvant" medications or "membrane stabilizers."

These medications help the body reprogram the messages involved in relaying the pain signals and include:

tricyclic and herocyclic antidepressants (Elavil, Nortryptalline, Desipramine, etc.) anticonvulsants (Neurontin, Lyrica, Keppra, Topomax, Dilantin, etc.) selective serotonin reuptake inhibitors (SSRI) antidepressants (Prozac, Paxil, Lexapro, Zoloft, etc.) selective norepinephrine reuptake inhibitors (SNRI) antidepressants (Effexor, Cymbalta) others such as beta blockers, alpha blockers, benzodiazepenes, etc.

Nerve pain is sub-classified as peripheral nerve pain, central nerve pain, and, by some pain authorities, as sympathetically mediated nerve pain, or pain involving the autonomic nervous system. There are specific "transmitters" for each of the nerve pathways that transmit messages from one nerve to another – these are called "neurotransmitters."

Determining if nerve pain is central or peripheral and then "inhibiting or accentuating" the pain signals requires knowledge and experience on the part of your physician.

The following table lists some of the neuropeptides and neurotransmitters involved in relaying pain messages.

Neuropeptides
Neurotransmitters
Glutamate (Primary Neuron)
Serotonin
Substance P (Primary Neuron)
Noradrenalin
NMDA (N-methyl-d-aspartate) (2o Neuron)
Dopamine
AMPA (2o Neuron)
GABA
Endorphins - Beta, encephalin, dynorphins
Acetylcholine
Neurotransmitter Therapy

We know that the neurotransmitters serotonin, noradrenalin, NMDA, Substance P, Glutamate and GABA are center stage players in increasing or decreasing nerve pain. It is vitally important to become familiar with the medications and/or nutritional supplements that augment the levels or increase the flow of these hormone messengers. Serotonin has become a household word because of its known effect on depression and its crucial role in treating migraine headaches. Serotonin may activate the central "gate" into the higher nervous system, including the brain, so that incoming signals from below the brain have more difficulty entering your consciousness. This is called increasing descending inhibition, or "raising the wall."

Medications that can raise serotonin include:

Nutritional substances L-tryptophane, or 5-hydroxy-tryptophane Prescription medications such as: fluoxetine (Prozac), sertraline (Zoloft), paroxetine (Paxil), ecitalopram (Lexapro).

Medications with noradrenaline activity also are effective in treating nerve or neuropathic pain conditions. Animal and human research suggests that medications with both noradrenaline and serotonin activity are the most effective of these drugs for neuropathic pain. Thus medications typically prescribed for nerve-related back or neck pain that radiates into the arms or legs include: duloxetene (Cymbalta), venlafaxine (Effexor), amitriptylene (Elavil), imipramine (Tofranil), desipramine (Norpramine), nortriptylene (Pamelor), and doxepin (Sinequan).

In other cases, raising central dopamine levels can relieve nerve pain and restore musculoskeletal movements. Medications that raise this neurotransmitter's level include amoxapine (Ascendin).

3. Nerve Blocking Medications

When nerve pain comes from an irritated nerve outside the spinal cord, there are two primary ways to block the pain. A physician must either block the peripheral nerve with local anesthetics or directly block the substances P and glutamate in the primary neuron.

Local anesthetics include novocaine, lidocaine, bupivacaine, ropivacaine or chirocaine. Primary neuron blocks include over-the-counter pepper creams and high-potency pepper cream, capsaicin (Zostrix), which depletes the neuron of substance P. Glutamate in the primary neuron can be partially blocked with gabapentin (Neurontin) or with glycine.

Treatment for pain related to secondary neurons—those next to the spinal cord—includes methadone (Dolophine), dextromethorphan, ketamine and amantadine.

For pain related to tertiary neurons — those in the brain — central acting agents work best. They include: gabapentin (Neurontin), topiramate (Topamax), tiagabine (Gabitril), phenytoin (Dilantin), valproic acid (Depakote), lamotragine (Lamictal) and carbamazapine (Tegretol).

4. Steroid Medications

Steroid medications are potent anti-inflammatory hormones that can be useful in easing pain and acute flare-ups in inflammation. Such medications include: methylprednisolone (Medrol), dexamethasone (Decadron), and prednisolone (Prednisone).

Comments: Steroid medications must be used with extreme caution, especially if they are used for longer than a short-time period (up to a week). Steroids can suppress the body's output of normal cortisone through the adrenal glands, inhibit the effectiveness of the white blood cells which fight off infection, cause fluid retention and swelling, and cause increased appetite and weight gain.

In terms of low back problems, steroids can cause bony resorption and osteoporosis. In diabetics, steroids can increase blood sugar. Because of these many complications, careful follow up is essential when using these medications

5. Botulinum toxin type A (Botox)

Botulinum toxin type A has been approved by the US Food and Drug Administration for the injection treatment of muscle spasm. Often used for painful muscle spasms all over the body, botulinum toxin type A takes about three to 10 days before the patient experiences relief. The effects of the medication last for three to four months. Patients may experience some side effects, including excessive paralysis or difficulty swallowing, but these are self-limiting. Patients may develop tolerance to botulinum toxin type A. When this occurs, botulinum toxin type B often can be helpful.

6. Botulinum toxin type B (Myobloc)

Botulinum toxin type B has been approved by the US Food and Drug Administration for treatment of cervical dystonia to reduce the severity of abnormal head position and neck pain. Cervical dystonia is a neurological movement disorder characterized by involuntary muscle contractions, which force the neck into abnormal, sometimes painful, movements or postures.

Botulinum toxin type B works by blocking the nerve impulses that control muscle movement. Botulinum toxin type B temporarily paralyzes the muscles, which prevents the involuntary muscle contractions associated with cervical dystonia. Although controlled studies remain to be done, anecdotal reports (case series, open label trials, etc) of response to botulinum toxin type B have been reported for pain management related to muscle stiffness, chronic lower back pain, movement disorders, and muscle spasticity related to stroke and multiple sclerosis, indicating that in individual cases, botulinum toxin type B may be helpful.

 

-Courtesy of the National Pain Foundation--   2008

Questions for potential- pain care providers

Posted by lladyfairhair - 12/23/08, 09:55 pm
Questions to Ask Potential Pain Care Providers

All practitioners have their own style, their own set of expertise, and their own limitations. The more informed you are, the better choice you are likely to make in choosing a Provider. It is your responsibility to make this choice. There is a better chance of success if you feel comfortable with your Provider from the beginning. And if your care is not working out to your satisfaction, then it is your responsibility to discuss this with your provider. You should feel empowered to make any changes necessary for you to feel satisfied with your professional relationship with all your provider, whether they provide pain care or not.

Below are some suggested questions you may want to ask your provider before you start treatment:

How often do you treat patients with my type of pain condition? What are your special qualifications to treat my pain condition? Have you participated in any special training about pain management techniques? What is your philosophy of managing my pain condition in terms of medications and alternative therapies? What types of medications do you usually prescribe? What types of non-medication therapies do you use? Where do you refer patients who need additional treatment? Is your clinic listed with any professional societies? Are you, or is someone in the clinic, available 24 hours a day if I need help? Who is in charge of my care plan? How often do I see that person? What should I expect from treatment with you and/or your team? What do you expect from me? What services may you recommend that are not covered by my insurance? How much do they cost? How can I make arrangements with you to pay for these services? If I would like you to communicate with:
a. my family, and/or
b. my other doctor(s), and/or
c. my employer, etc,
How do we make arrangements for that? Or, I do not wish you to discuss my condition with anyone else. Is that a reasonable arrangement for my condition?

Advertisement
Content on DailyStrength.org is for informational purposes only. We do not provide any medical advice, diagnosis or treatment. More info
Portions of support group and treatment information provided by Wikipedia under the GNU FDL license
Copyright 2006-2009, DailyStrength, Inc. All rights reserved.
Terms of Service | Privacy Policy | Report Abuse | HSW International | HSW China | HSW Brazil